Inside The Government Decision That Opened Up Abortion Pill Floodgates

Peer-Reviewed Article: FDA Lacked Evidence to Drop In-Person Abortion Drug Requirement - Lozier Institute

New article shows FDA lacked justification for concluding safety of in-person dispensing requirement for mifepristone Washington D.C. — A new peer-reviewed article on the Food and Drug Administration’s (FDA) 2021 complete review of mifepristone’s Risk Evaluation and Mitigation Strategy (REMS) program provisions found the agency lacked sufficient evidence to justify removal of the in-person dispensing […]

Here’s Why the 2021 FDA Review of Mifepristone Was Problematic

A new peer-reviewed article on the Food and Drug Administration’s (FDA) 2021 complete review of mifepristone’s Risk Evaluation and Mitigation Strategy (REMS) program provisions found the agency lacked sufficient evidence to justify removal of the in-person dispensing requirement. The paper, authored by Charlotte Lozier Institute (CLI) scholars and published in Issues in Law and Medicine, […]

Inside The Government Decision That Opened Up Abortion Pill Floodgates

A decision from the Food and Drug Administration that opened up the floodgates of mail-order abortions relied on deeply flawed evidence, a group of researchers found.  Scholars with the pro-life Charlotte Lozier Institute argued in a paper published Tuesday and shared with The Daily Wire that the FDA’s 2021 decision to allow the abortion pill mifepristone to be mailed without an in-person appointment fell significantly short of scientific standa…